Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act). The ...
Dr. Douglas Unis, Founder and Chief Medical Officer ... the system’s advantages in actual surgical settings. As Monogram prepares for commercialization, it is also working on system enhancements ...
I'm incredibly impressed and confident that surgeons will recognize the impact of this system," said Dr. Douglas Unis, Founder and Chief Medical Officer of Monogram. "Navigating a regulatory ...
"The Investigator Meeting was a successful milestone in the preparation for Monogram's clinical trial," said Dr. Ajaykumar Yadav, Associate Vice President and Group Head of Clinical Research at ...
Monogram May Market the Monogram mBôs™ TKA ... "I want to personally thank Kamran Shamaei and Dr. Douglas Unis for their vision, dedication, and contributions to this achievement.